(S) Etifoxine Development Fund, LLC
SEDF funding the FDA approval process for a uniquely low risk, non-opiate, non-addictive, non-sedating, pain drug without GI side effects.
- Stage Product In Development
- Industry Biotechnology
- Location Metairie, LA, USA
- Currency USD
- Founded May 2012
- Employees 0
- Website ng-dg.com
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.